Global Valganciclovir Market Size, Share and Trends Analysis Report, By Dosage Form (Tablets, and Powder), Application (HIV/AIDS and Organ Transplant), and By Distribution Channel (Hospital Pharmacies, and Retail Drug Stores), Forecast (2022-2028)

The global valganciclovir market is anticipated to grow at a considerable CAGR of 4.9% during the forecast period (2022-2028). Valganciclovir is an antiviral drug used for the treatment of cytomegalovirus in patients suffering from HIV/AIDS or after the procedure of organ transplant. The medication is taken for a long duration as it only suppresses the virus without curing it. The major factor attributing to the growth of the global valganciclovir market is the increasing prevalence of HIV/AIDS across the globe. According to a report published by the World Health Organisation (WHO), the major global public health issue is considered to be HIV/AIDS affecting around 37.7 million people at the end of 2020. Among these, 2/3 of the people are from the African region. The recorded mortality due to HIV/AIDS is around 6,80,000 people. HIV/AIDS has no cure, it can only be prevented or taken care of through various medications such as valganciclovir in the long term for healthy living.

Furthermore, the increasing number of organ transplant procedures are also increasing the infection of cytomegalovirus in patients. Thus, increasing the demand for valganciclovir drugs for the treatment of cytomegalovirus. According to the Health Resources & Services Administration (HRSA), more than 40,000 organ transplant procedures are done in 2021 with around 1,06,204 people including men, women, and children on the national transplant waiting list. A person is added to the transplant waiting list every 9 minutes. In addition, several developments are done in the valganciclovir drug for better application. For instance, in December 2021, valganciclovir and nanatinostat got the orphan drug designation from the Food and Drug Administration (FDA) for the treatment of Epstein Barr virus-positive diffuse large B-cell lymphoma. There are two phase 2 clinical trials going on by Viracta Therapeutics for testing the efficacy of valganciclovir on Epstein Barr virus.

The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in June 2020, Entero Healthcare Solutions done an agreement with Roche Products (India) Pvt. Ltd. for the distribution of Roche’s nephrology drugs, including valganciclovir (Valcyte). Roche’s Valcyte is now distributed by Entero Healthcare Solutions in India.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Dosage Form
  • By Application
  • By Distribution Channel
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- F. Hoffmann-La Roche Ltd., Cipla Ltd., Jolly Health Care, Genetech, Inc., and Anthem Biosciences Pvt. Ltd., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Valganciclovir  Market Report by Segment

By Dosage Form

• Tablets
• Powder

By Application

• HIV/AIDS
• Organ Transplant

By Distribution Channel

• Hospital Pharmacies
• Retail Drug Stores

Global Valganciclovir  Market Report by Region

North America

• The United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa